Qingfei Expectorant Patry Clinical Observation Of Treatment Of Bronchiectasis Acute Exacerbation Of (Phlegm Obstruct The Pulmonary Type)

Objective:This study was designed to investigate the efficacy of self Qingfeiexpectorant side phlegm obstruct the pulmonary type of bronchiectasis,and further from the theoretical and clinical studies to investigate themechanism of action of Qingfei expectorant soup to alleviatebronchiectasis symptoms, reduce antimicrobial drug use, improve thequality of life in patients with new treatment ideas.Methods:40patients met the the bronchiectasis Western diagnostic criteriaand Chinese medicine bronchiectasis phlegm obstruct the lungDiagnostic Criteria patients were randomly divided into treatment groupand control group20cases (excluding hemoptysis greater on the100ml/24h). The control group was treated with western medicine: thelevofloxacin lactate, sodium chloride injection, ambroxol hydrochlorideinjection in the treatment, a small amount of hemoptysis (<10ml/24h) bean envelope of blood tablets oral, hemoptysis50ml/24h who areinjection thrombin treatment; the hemoptysis50ml/24h the pituitary beYesu Jing drops. Treatment group be based on self Chinese medicinedecoction clearing the lungs phlegm soup (Morus alba, skullcap,Houttuynia, bellflower, bamboo shavings, Tianzhu Huang, Trichosanthes skin, Citrus aurantium, Suzi, fried radish seed, goldboiling grass, hibiscus flowers, Fritillaria, forsythia, etc.) treatment,clinical and subtraction. Treatment for10days. Compare the clinicalefficacy of the two groups of patients before and after treatmentsymptoms integral to improve the situation, the main symptoms ofpatients (such as body temperature, cough, sputum, hemoptysis)recovery time, blood inflammatory markers before and after treatment.Results1.Comparison of clinical efficacy: the total efficiency of the clinicalefficacy of the treatment group (95%) higher than that of the controlgroup (65%), the treatment group was (80%) than in the treatmentgroup was (40%), there are significant differences sex (P<0.05);2. two sets of symptom scores before and after treatment improveboth differences (P<0.05), symptom scores improve treatment groupthanthe control group (P<0.05);3. the recovery time of the main symptoms of the treatment group(such as body temperature, cough, sputum production, hemoptysis, etc.)than the control group short, there is a significant difference(P<0.05),with statistical significance.It has the chance that can reduce the time oftreatment, to reduce the use of antimicrobial agents to reduce thegeneration of resistant, to reduce the economic burden4. two sets of blood inflammatory markers before and aftertreatment compared, there is a significant difference (P <0.01) thanbefore, prompted two groups of treatment can reduce bloodinflammatory markers, and infection control. The treatment groupcompared to the control group, but also differences (P <0.05), thetreatment group learn inflammatory markers improve the control group,the control of infections better. Conclusion:This clinical study showed that phlegm obstruct thelung-bronchodilator therapy, the treatment group in clinical efficacy,symptom improvement was significantly better than the control groupwith western medicine alone, non-toxic side effects and safety. Inclinical and research to further carry forward the application IntegrativeMedicine bronchiectasis, not only to improve the clinical efficacy,especially in improving the patient’s symptoms and improve the qualityof daily life, traditional Chinese medicine has played a greateradvantage to reduce the use of antimicrobial agents to reduce theeconomic burden of the patients. Visible, Qingfei expectorant soup athe exact clinical efficacy.